Nitrogen-containing heterocyclic drug products approved by the FDA in 2023: Synthesis and biological activity
Year: 2024
Type: review
Institutions: University of South China, Hunan University of Medicine
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W4402312238
